This corrective action of cancer on SARS-CoV-2-related inflammation does not seem to be unidirectional as COV/CA patients display enhanced activation of HLA-DR+CD38+CD4+ T cells, and increased IFNγ expression in PBMCs. The gene discussed is CD38; the disease is cancer.